TrialAssure debuts clinical data anonymization software

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/solarseven)
(Image: Getty/solarseven)

Related tags: TrialAssure, Clinical data, SaaS, Clinical trial, Clinical trial data, Patient centricity, Big data

TrialAssure releases anonymizing SaaS to enable sponsors to share clinical trial data, as the industry shifts towards utilizing big data while maintaining patient privacy.

The limited release of TrialAssure’s latest software-as-a-service (SaaS) application, Anonymize, will allow sponsors to anonymize clinical trial data automatically, to ease challenges that may arise when sharing data while still maintaining patient privacy.

TrialAssure stated that the SaaS will anonymize this data using industry-standard techniques that can be reused and customized for each dataset. It also has the capability to assign a risk score associated with the re-identification of transformed data, based upon thresholds set by the sponsor.

“The pharmaceutical industry is moving towards sharing data more openly. Health authorities and scientific journal editors alike may require greater levels of data transparency in the not-so-distant future,”​ Mohamad Zahreddine, CIO of TrialAssure, said in a statement.

End users can build a library of custom and reusable variables to reapply the same anonymization rules across studies, in which over time, a library develops to make the total process more efficient.

“In the age of big data, research organizations can leverage pre-existing, anonymized data to speed-up the development process for life-changing medicines,”​ Zahreddine continued.

Anonymize will join the ranks of TrialAssure’s suite of transparency tools ​that allow for the sharing of information across health authorities without compromising patient privacy.

TrialAssure was unable to respond to our request for comment

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars